Bristol Myers posts quarterly loss, revenue rises 5%
Bristol Myers Squibb on Thursday reported a first-quarter loss as charges related to its recent acquisitions of Karuna Therapeutics, RayzeBio…
58,700$
-0,20%
Echtzeit-Aktienkurs Mirati Therapeutics Inc.
Bid:
Ask: